1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Dutton, J.L.
Bansal, P.S.
Hogg, R.C.
Adams, D.J.
Alewood, P.F.
Craik, D.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
277
48849
48857
10.1074/jbc.M208842200
12376538
A New Level of Conotoxin Diversity, a Non-native Disulfide Bond Connectivity in alpha -Conotoxin AuIB Reduces Structural Definition but Increases Biological Activity.
2002
10.2210/pdb1mxp/pdb
pdb_00001mxp
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
1575.788
alpha-conotoxin AuIB
1
syn
polymer
no
yes
GCCSYPPCFATNPDC(NH2)
GCCSYPPCFATNPDCX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-12-30
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
1MXN contains Solution structure of the same protein with native disulfide bond connectivity
RCSB
Y
PDBJ
2002-10-03
REL
REL
The peptide was synthesised by BOC chemistry.
sample
structures with the least restraint violations,structures with the lowest energy
50
20
2D NOESY
2D TOCSY
DQF-COSY
E-COSY
2D NOESY
2D TOCSY
3.5
atmospheric
atm
280
K
140 noe restraints were used including 4 long and 13 medium range noes, also 3 dihedral angles were included
simulated annealing, molecular dynamics, energy minimisation in a CHARM force field
7
closest to the average
2mM ribbon AuIB peptide
90% H2O/10% D2O
2mM ribbon AuIB peptide
100% D2O
Bruker
collection
XwinNMR
2.6
Bruker
processing
XwinNMR
2.6
Brunger
refinement
X-PLOR
3.851 then 3.1f
Brunger
structure solution
X-PLOR
3.851 then 3.1f
750
Bruker
DMX
500
Bruker
ARX
GLY
1
n
1
GLY
1
A
CYS
2
n
2
CYS
2
A
CYS
3
n
3
CYS
3
A
SER
4
n
4
SER
4
A
TYR
5
n
5
TYR
5
A
PRO
6
n
6
PRO
6
A
PRO
7
n
7
PRO
7
A
CYS
8
n
8
CYS
8
A
PHE
9
n
9
PHE
9
A
ALA
10
n
10
ALA
10
A
THR
11
n
11
THR
11
A
ASN
12
n
12
ASN
12
A
PRO
13
n
13
PRO
13
A
ASP
14
n
14
ASP
14
A
CYS
15
n
15
CYS
15
A
CYS
15
n
16
NH2
16
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
ASN
PRO
12
13
149.44
1
8.42
1.10
114.20
122.62
A
A
A
CA
CB
SG
CYS
CYS
CYS
2
2
2
N
1
12.76
1.10
114.20
126.96
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
5
8.09
1.10
114.20
122.29
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
5
6.99
1.10
114.20
121.19
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
7
7.49
1.10
114.20
121.69
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
7
6.83
1.10
114.20
121.03
A
A
A
CA
CB
SG
CYS
CYS
CYS
15
15
15
N
9
10.18
1.10
114.20
124.38
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
9
9.41
1.10
114.20
123.61
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
11
6.63
1.10
114.20
120.83
A
A
A
CA
CB
SG
CYS
CYS
CYS
15
15
15
N
13
10.04
1.10
114.20
124.24
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
13
7.06
1.10
114.20
121.26
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
15
7.24
1.10
114.20
121.44
A
A
A
CA
CB
SG
CYS
CYS
CYS
15
15
15
N
17
7.22
1.10
114.20
121.42
A
A
A
CA
CB
SG
CYS
CYS
CYS
3
3
3
N
17
7.95
1.10
114.20
122.15
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
19
7.21
1.10
114.20
121.41
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
1
A
PHE
9
-67.13
-73.22
1
A
THR
11
-169.30
30.28
1
A
ASP
14
-165.03
56.85
2
A
PHE
9
-90.39
48.09
2
A
ALA
10
-49.73
-18.47
2
A
THR
11
-83.97
35.45
3
A
ALA
10
-49.47
-72.01
4
A
PHE
9
-60.05
-114.68
4
A
ASP
14
-91.82
54.29
5
A
CYS
2
-170.68
-54.41
5
A
ASN
12
116.94
-45.25
6
A
CYS
2
-76.57
-133.51
7
A
CYS
2
-58.31
-79.35
7
A
PHE
9
-68.76
80.84
7
A
ALA
10
-49.60
-19.71
8
A
PHE
9
-69.83
-127.12
8
A
ALA
10
-80.24
-89.58
8
A
THR
11
172.96
56.10
8
A
ASP
14
-87.98
43.69
9
A
ASN
12
-163.64
-45.51
9
A
ASP
14
-176.70
34.17
10
A
PHE
9
-66.67
-120.21
10
A
THR
11
37.69
45.86
10
A
ASP
14
-88.19
42.24
12
A
ALA
10
-48.91
83.56
12
A
ASN
12
110.11
-53.66
13
A
CYS
2
-171.64
-63.32
13
A
ASP
14
153.43
83.20
14
A
CYS
2
-55.95
-78.01
14
A
CYS
3
-106.37
78.78
14
A
ALA
10
-55.22
-81.77
14
A
THR
11
-145.02
59.78
15
A
CYS
2
-163.27
-98.20
15
A
ALA
10
-52.16
77.56
15
A
THR
11
26.08
52.72
16
A
CYS
2
-57.59
-79.90
16
A
PHE
9
-69.04
-124.12
16
A
ALA
10
-79.33
-89.87
16
A
THR
11
165.52
61.98
17
A
CYS
2
-167.56
-48.67
17
A
ALA
10
-49.18
-77.96
17
A
THR
11
-178.65
35.39
17
A
ASP
14
157.24
80.91
18
A
PHE
9
-65.18
-105.69
18
A
ASP
14
-109.93
49.26
19
A
CYS
3
-48.32
168.21
19
A
SER
4
-139.81
-40.03
19
A
ALA
10
-49.85
-18.86
19
A
THR
11
-84.24
36.10
19
A
ASP
14
-165.51
103.70
20
A
CYS
2
57.86
4.56
20
A
PHE
9
-83.15
-137.08
20
A
ASN
12
-154.53
-39.25
20
A
ASP
14
-162.38
101.49
Solution structure of the ribbon disulfide bond isomer of alpha-conotoxin AuIB
1
N
N
disulf
2.029
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
15
A
SG
CYS
15
1_555
disulf
2.023
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
8
A
SG
CYS
8
1_555
covale
1.304
both
A
CYS
15
A
C
CYS
15
1_555
A
NH2
16
A
N
NH2
16
1_555
TOXIN
turns, TOXIN
CXA2_CONAL
UNP
1
1
P56640
GCCSYPPCFATNPDC
1
15
1MXP
1
15
P56640
A
1
1
15
BINDING SITE FOR RESIDUE NH2 A 16
A
NH2
16
Software
2
A
PHE
9
A
PHE
9
2
1_555
A
CYS
15
A
CYS
15
2
1_555